Supraclavicular Versus Interscalene Block for Shoulder Surgery
NCT ID: NCT02486549
Last Updated: 2017-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
62 participants
INTERVENTIONAL
2015-06-30
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Interscalene Block and Suprascapular With Axillary Block
NCT04822610
Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block
NCT07278050
Interscalene Versus Infraspinatus-Teres Minor Blocks for Arthroscopic Shoulder Surgery
NCT07253740
Ultrasound-Guided Erector Spinae Plane Block Following Arthroscopic Shoulder Surgery
NCT04081948
Comparison of the Analgesic Effects of Continuous Versus Single-Shot Serratus Posterior Superior Intercostal Plane Block in Arthroscopic Shoulder Surgery
NCT06826846
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supraclavicular Block
Ultrasound guided supraclavicular block with 20 ml of 0.25% bupivacaine will be performed
Supraclavicular Block
Under ultrasound guidance an insulated needle is advanced with in- plane technique into the brachial plexus sheath and 20ml 0.25% bupivacaine will be administered
Bupivacaine
20ml 0.25% bupivacaine will be injected for brachial plexus block
Ultrasound
The Ultrasound will be used for brachial plexus visualization
Interscalene block
Ultrasound guided inter scalene block with 20ml of 0.25% bupivacaine will be performed.
Interscalene Block
Under ultrasound guidance an insulated needle will be placed through the middle scalene muscle,into the interscalene groove with in-plane technique and 20ml 0.25%bupivacaine will be administered into the brachial plexus
Bupivacaine
20ml 0.25% bupivacaine will be injected for brachial plexus block
Ultrasound
The Ultrasound will be used for brachial plexus visualization
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Supraclavicular Block
Under ultrasound guidance an insulated needle is advanced with in- plane technique into the brachial plexus sheath and 20ml 0.25% bupivacaine will be administered
Interscalene Block
Under ultrasound guidance an insulated needle will be placed through the middle scalene muscle,into the interscalene groove with in-plane technique and 20ml 0.25%bupivacaine will be administered into the brachial plexus
Bupivacaine
20ml 0.25% bupivacaine will be injected for brachial plexus block
Ultrasound
The Ultrasound will be used for brachial plexus visualization
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* chronic opioid use,
* ipsilateral upper limb neurological deficits,
* severe respiratory disease,
* coagulopathy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tokat Gaziosmanpasa University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuğba Karaman
Assistant Professor, M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tugba Karamanaraman, M.D.
Role: PRINCIPAL_INVESTIGATOR
Gaziosmanpasa University Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa University Medical School
Tokat Province, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
artroscopy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.